LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Household food insecurity, maternal nutrition, environmental risks and infants' health outcomes: protocol of the IMPALA birth cohort study in Uganda.

    Terfa, Zelalem G / Nantanda, Rebecca / Lesosky, Maia / Devereux, Graham / Obasi, Angela / Mortimer, Kevin / Khan, Jahangir / Rylance, Jamie / Niessen, Louis Wihelmus

    BMJ open

    2022  Volume 12, Issue 3, Page(s) e050729

    Abstract: Introduction: In low- and middle-income countries (LMICs), food insecurity and undernutrition disproportionately affect women of reproductive age, infants and young children. The disease burden from undernutrition in these vulnerable sections of ... ...

    Abstract Introduction: In low- and middle-income countries (LMICs), food insecurity and undernutrition disproportionately affect women of reproductive age, infants and young children. The disease burden from undernutrition in these vulnerable sections of societies remains a major concern in LMICs. Biomass fuel use for cooking is also common in LMICs. Empirical evidence from high-income countries indicates that early life nutritional and environmental exposures and their effect on infant lung function are important; however, data from sub-Saharan Africa are scarce.
    Aim: To estimate the association between infant lung function and household food insecurity, energy poverty and maternal dietary diversity.
    Methods and analysis: Pregnant women will be recruited in an existing Health and Demographic Surveillance Site in South-West Uganda. Household food insecurity, sources and uses of energy, economic measures and maternal dietary diversity will be collected during pregnancy and after birth. Primary health outcomes will be infant lung function determined by tidal breath flow and volume analysis at 6-10 weeks of age. Infant weight and length will also be collected.A household Food Consumption Score and Minimum Dietary Diversity for Women (MDD-W) indicator will be constructed. The involved cost of dietary diversity will be estimated based on MDD-W. The association between household level and mothers' food access indicators and infant lung function will be evaluated using regression models. The Multidimensional Energy Poverty Index (MEPI) will be estimated and used as an indicator of households' environmental exposures. The association between household MEPI and infant lung function will be assessed using econometric models.
    Ethics and dissemination: Ethical approvals have been obtained from Liverpool School of Tropical Medicine (18-059), the Uganda Virus Research Institute Ethics Committee (097/2018) and Uganda National Council for Science and Technology (SS 4846). Study results will be shared with participants, policy-makers, other stakeholders and published in peer-reviewed journals.
    MeSH term(s) Birth Cohort ; Child ; Child, Preschool ; Cohort Studies ; Female ; Food Insecurity ; Food Supply ; Humans ; Infant ; Pregnancy ; Uganda/epidemiology
    Language English
    Publishing date 2022-03-18
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2021-050729
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial.

    Euden, Joanne / Thomas-Jones, Emma / Aston, Stephen / Brookes-Howell, Lucy / Carman, Julie / Carrol, Enitan / Gilbert, Stephanie / Howard, Philip / Hood, Kerenza / Inada-Kim, Matthew / Llewelyn, Martin / McGill, Fiona / Milosevic, Sarah / Niessen, Louis Wihelmus / Nsutebu, Emmanuel / Pallmann, Philip / Schmidt, Paul / Taylor-Robinson, David / Welters, Ingeborg /
    Todd, Stacy / French, Neil

    BMJ open

    2022  Volume 12, Issue 6, Page(s) e063424

    Abstract: Introduction: Sepsis is a common, potentially life-threatening complication of infection. The optimal treatment for sepsis includes prompt antibiotics and intravenous fluids, facilitated by its early and accurate recognition. Currently, clinicians ... ...

    Abstract Introduction: Sepsis is a common, potentially life-threatening complication of infection. The optimal treatment for sepsis includes prompt antibiotics and intravenous fluids, facilitated by its early and accurate recognition. Currently, clinicians identify and assess severity of suspected sepsis using validated clinical scoring systems. In England, the National Early Warning Score 2 (NEWS2) has been mandated across all National Health Service (NHS) trusts and ambulance organisations. Like many clinical scoring systems, NEWS2 should not be used without clinical judgement to determine either the level of acuity or a diagnosis. Despite this, there is a tendency to overemphasise the score in isolation in patients with suspected infection, leading to the overprescription of antibiotics and potentially treatment-related complications and rising antimicrobial resistance. The biomarker procalcitonin (PCT) has been shown to be useful in specific circumstances to support appropriate antibiotics prescribing by identifying bacterial infection. PCT is not routinely used in the care of undifferentiated patients presenting to emergency departments (EDs), and the evidence base of its optimal usage is poor. The PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal (PRONTO) study is a randomised controlled trial (RCT) in adults with suspected sepsis presenting to the ED to compare standard clinical management based on NEWS2 scoring plus PCT-guided risk assessment with standard clinical management based on NEWS2 scoring alone and compare if this approach reduces prescriptions of antibiotics without increasing mortality.
    Methods and analysis: PRONTO is a parallel two-arm open-label individually RCT set in up to 20 NHS EDs in the UK with a target sample size of 7676 participants. Participants will be randomised in a ratio of 1:1 to standard clinical management based on NEWS2 scoring or standard clinical management based on NEWS2 scoring plus PCT-guided risk assessment. We will compare whether the addition of PCT measurement to NEWS2 scoring can lead to a reduction in intravenous antibiotic initiation in ED patients managed as suspected sepsis, with at least no increase in 28-day mortality compared with NEWS2 scoring alone (in conjunction with local standard care pathways). PRONTO has two coprimary endpoints: initiation of intravenous antibiotics at 3 hours (superiority comparison) and 28-day mortality (non-inferiority comparison). The study has an internal pilot phase and group-sequential stopping rules for effectiveness and futility/safety, as well as a qualitative substudy and a health economic evaluation.
    Ethics and dissemination: The trial protocol was approved by the Health Research Authority (HRA) and NHS Research Ethics Committee (Wales REC 2, reference 20/WA/0058). In England and Wales, the law allows the use of deferred consent in approved research situations (including ED studies) where the time dependent nature of intervention would not allow true informed consent to be obtained. PRONTO has approval for a deferred consent process to be used. Findings will be disseminated through peer-reviewed journals and presented at scientific conferences.
    Trial registration number: ISRCTN54006056.
    MeSH term(s) Adult ; Anti-Bacterial Agents/therapeutic use ; Bacterial Infections/drug therapy ; Emergency Service, Hospital ; Humans ; Multicenter Studies as Topic ; Procalcitonin ; Randomized Controlled Trials as Topic ; Sepsis/diagnosis ; Sepsis/drug therapy
    Chemical Substances Anti-Bacterial Agents ; Procalcitonin
    Language English
    Publishing date 2022-06-13
    Publishing country England
    Document type Clinical Trial Protocol ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2022-063424
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Integrating health services for HIV infection, diabetes and hypertension in sub-Saharan Africa: a cohort study.

    Birungi, Josephine / Kivuyo, Sokoine / Garrib, Anupam / Mugenyi, Levicatus / Mutungi, Gerald / Namakoola, Ivan / Mghamba, Janneth / Ramaiya, Kaushik / Wang, Duolao / Maongezi, Sarah / Musinguzi, Joshua / Mugisha, Kenneth / Etukoit, Bernard M / Kakande, Ayoub / Niessen, Louis Wihelmus / Okebe, Joseph / Shiri, Tinevimbo / Meshack, Shimwela / Lutale, Janet /
    Gill, Geoff / Sewankambo, Nelson / Smith, Peter G / Nyirenda, Moffat J / Mfinanga, Sayoki Godfrey / Jaffar, Shabbar

    BMJ open

    2021  Volume 11, Issue 11, Page(s) e053412

    Abstract: Background: HIV, diabetes and hypertension have a high disease burden in sub-Saharan Africa. Healthcare is organised in separate clinics, which may be inefficient. In a cohort study, we evaluated integrated management of these conditions from a single ... ...

    Abstract Background: HIV, diabetes and hypertension have a high disease burden in sub-Saharan Africa. Healthcare is organised in separate clinics, which may be inefficient. In a cohort study, we evaluated integrated management of these conditions from a single chronic care clinic.
    Objectives: To determined the feasibility and acceptability of integrated management of chronic conditions in terms of retention in care and clinical indicators.
    Design and setting: Prospective cohort study comprising patients attending 10 health facilities offering primary care in Dar es Salaam and Kampala.
    Intervention: Clinics within health facilities were set up to provide integrated care. Patients with either HIV, diabetes or hypertension had the same waiting areas, the same pharmacy, were seen by the same clinical staff, had similar provision of adherence counselling and tracking if they failed to attend appointments.
    Primary outcome measures: Retention in care, plasma viral load.
    Findings: Between 5 August 2018 and 21 May 2019, 2640 patients were screened of whom 2273 (86%) were enrolled into integrated care (832 with HIV infection, 313 with diabetes, 546 with hypertension and 582 with multiple conditions). They were followed up to 30 January 2020. Overall, 1615 (71.1%)/2273 were female and 1689 (74.5%)/2266 had been in care for 6 months or more. The proportions of people retained in care were 686/832 (82.5%, 95% CI: 79.9% to 85.1%) among those with HIV infection, 266/313 (85.0%, 95% CI: 81.1% to 89.0%) among those with diabetes, 430/546 (78.8%, 95% CI: 75.4% to 82.3%) among those with hypertension and 529/582 (90.9%, 95% CI: 88.6 to 93.3) among those with multimorbidity. Among those with HIV infection, the proportion with plasma viral load <100 copies/mL was 423(88.5%)/478.
    Conclusion: Integrated management of chronic diseases is a feasible strategy for the control of HIV, diabetes and hypertension in Africa and needs evaluation in a comparative study.
    MeSH term(s) Ambulatory Care Facilities ; Cohort Studies ; Diabetes Mellitus/epidemiology ; Diabetes Mellitus/therapy ; Female ; HIV Infections/complications ; HIV Infections/epidemiology ; HIV Infections/therapy ; Health Services ; Humans ; Hypertension/epidemiology ; Hypertension/therapy ; Prospective Studies ; Tanzania ; Uganda
    Language English
    Publishing date 2021-11-02
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2021-053412
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Article ; Online: Integrating HIV, diabetes and hypertension services in Africa: study protocol for a cluster randomised trial in Tanzania and Uganda.

    Mfinanga, Sayoki Godfrey / Nyirenda, Moffat J / Mutungi, Gerald / Mghamba, Janneth / Maongezi, Sarah / Musinguzi, Joshua / Okebe, Joseph / Kivuyo, Sokoine / Birungi, Josephine / van Widenfelt, Erik / Van Hout, Marie-Claire / Bachmann, Max / Garrib, Anupam / Bukenya, Dominic / Cullen, Walter / Lazarus, Jeffrey V / Niessen, Louis Wihelmus / Katahoire, Anne / Shayo, Elizabeth Henry /
    Namakoola, Ivan / Ramaiya, Kaushik / Wang, Duolao / Cuevas, L E / Etukoit, Bernard M / Lutale, Janet / Meshack, Shimwela / Mugisha, Kenneth / Gill, Geoff / Sewankambo, Nelson / Smith, Peter G / Jaffar, Shabbar

    BMJ open

    2021  Volume 11, Issue 10, Page(s) e047979

    Abstract: Introduction: HIV programmes in sub-Saharan Africa are well funded but programmes for diabetes and hypertension are weak with only a small proportion of patients in regular care. Healthcare provision is organised from stand-alone clinics. In this ... ...

    Abstract Introduction: HIV programmes in sub-Saharan Africa are well funded but programmes for diabetes and hypertension are weak with only a small proportion of patients in regular care. Healthcare provision is organised from stand-alone clinics. In this cluster randomised trial, we are evaluating a concept of integrated care for people with HIV infection, diabetes or hypertension from a single point of care.
    Methods and analysis: 32 primary care health facilities in Dar es Salaam and Kampala regions were randomised to either integrated or standard vertical care. In the integrated care arm, services are organised from a single clinic where patients with either HIV infection, diabetes or hypertension are managed by the same clinical and counselling teams. They use the same pharmacy and laboratory and have the same style of patient records. Standard care involves separate pathways, that is, separate clinics, waiting and counselling areas, a separate pharmacy and separate medical records. The trial has two primary endpoints: retention in care of people with hypertension or diabetes and plasma viral load suppression. Recruitment is expected to take 6 months and follow-up is for 12 months. With 100 participants enrolled in each facility with diabetes or hypertension, the trial will provide 90% power to detect an absolute difference in retention of 15% between the study arms (at the 5% two-sided significance level). If 100 participants with HIV infection are also enrolled in each facility, we will have 90% power to show non-inferiority in virological suppression to a delta=10% margin (ie, that the upper limit of the one-sided 95% CI of the difference between the two arms will not exceed 10%). To allow for lost to follow-up, the trial will enrol over 220 persons per facility. This is the only trial of its kind evaluating the concept of a single integrated clinic for chronic conditions in Africa.
    Ethics and dissemination: The protocol has been approved by ethics committee of The AIDS Support Organisation, National Institute of Medical Research and the Liverpool School of Tropical Medicine. Dissemination of findings will be done through journal publications and meetings involving study participants, healthcare providers and other stakeholders.
    Trial registration number: ISRCTN43896688.
    MeSH term(s) Ambulatory Care Facilities ; Diabetes Mellitus/therapy ; HIV Infections/therapy ; Humans ; Hypertension/epidemiology ; Hypertension/therapy ; Randomized Controlled Trials as Topic ; Tanzania ; Uganda/epidemiology
    Language English
    Publishing date 2021-10-13
    Publishing country England
    Document type Clinical Trial Protocol ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2020-047979
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top